Your session is about to expire
← Back to Search
Inulin for ICU Infections
Study Summary
This trial will test whether inulin is safe and may help to prevent antibiotic resistant infections in the ICU.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I am 18 years old or older.I have taken broad-spectrum antibiotics in the last 24 hours.I cannot take in fluids by mouth or through the gut.I am currently admitted in a medical ICU that is part of the study.I am immunosuppressed due to a solid organ transplant or specific medications.I have sepsis with a significant increase in my SOFA score.I can start the study within 4 hours of being admitted to the ICU.I cannot give consent and have no one legally allowed to do so for me.I have sepsis with a significant increase in my SOFA score.I have had recent intestinal surgery or have narrowings in my intestines.You are allergic to inulin.I am currently admitted in a medical ICU that is part of the study.
- Group 1: Placebo
- Group 2: Inulin 32 g/day
- Group 3: Inulin 16 g/day
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the consumption of broad-spectrum antibiotics sanctioned by the FDA?
"The safety of Broad-spectrum antibiotics is rated as a 2 due to the available evidence that suggests its safety, however there has yet to be sufficient data demonstrating efficacy."
Are there any available spots to join this medical investigation?
"Clinicaltrials.gov is currently advertising this medical trial, which was first uploaded on October 14th 2019 and has been recently revised as of October 11th 2022."
What other studies have been done to assess the efficacy of broad-spectrum antibiotics?
"Presently, there are two medical investigations into Broad-spectrum antibiotics that haven't yet reached their final stage. Both studies emanate from Changsha in Hunan and have advanced to Phase 2."
To what extent are participants being treated in this trial?
"Affirmative. According to clinicaltrials.gov, this study is still in progress and accepting participants since its inception on October 14th 2019 as of the most recent update on October 11th 2022. Ninety individuals are needed across a single site for enrollment purposes."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger